上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。
名称 | Copeptin (human) |
编码 | [78362-34-2] |
别名 | Copeptin (human) |
纯度 | 80%,90%,95%,98%,99% |
重量 | 1mg,5mg,10mg,50mg,100mg,1g |
序列(单字母缩写) | ASDRSNATQLDGPAGALLLRLVQLAGAPEPFEPAQPDAY |
序列(三字母缩写) | H-Ala-Ser-Asp-Arg-Ser-Asn-Ala-Thr-Gln-Leu-Asp-Gly-Pro-Ala-Gly-Ala-Leu-Leu-Leu-Arg-Leu-Val-Gln-Leu-Ala-Gly-Ala-Pro-Glu-Pro-Phe-Glu-Pro-Ala-Gln-Pro-Asp-Ala-Tyr-OH (trifluoroacetate salt) |
基本描述 | Exendin (9-39) is a selective and potent against glucagon-like peptide 1 (GLP-1) and inhibits (Kd = 1.7 nm) cAMP production caused by Gastric Inhibitory Peptide (GIP). Exendin (9-39) is involved in appetite modulation by reducing insulin secretion and helps prevent sharp falls in glucose levels. This peptide has been studied for its? effects on the permeability of basal microvascular. |
溶解度 | |
分子量 | 4021.46 |
化学式 | C177H279N49O58 |
存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
注释 | |
Documents | |
Figures | |
Reference | J.Struck et al., Peptides, 26, 2500 (2005) N.G.Morgenthaler et al., Clin. Chem., 52, 112 (2006) S.Q.Khan et al., Circulation, 115, 2103 (2007) G.Szinnai et al., J. Clin. Endocrinol. Metab., 92, 3973 (2007) M.Katan et al., Crit. Care, 12, 117 (2008) R.Seligman et al., Crit. Care, 12, R11 (2008) |
C端 | |
N端 | |
化学桥 |